IndieBio (part of SOSV) is a biotech investor and accelerator that has started shifting more and more toward climate tech in recent years. The current cohort is batch 13, for fall 2022, and we’ve taken a closer look at the five that stood out the most.
Recent data suggests that certain populations may have distinct experiences and reactions to sedation and pain management, underscoring the need for
Trusted site to Buy Clonazepam culturally competent care. Safety behaviors are actions
Best place to Buy Tramadol Online individuals take to protect themselves from
Buy Prednisone Online Without Prescription perceived threats, and they often arise from anxiety or fear related to sleep. Researchers and healthcare professionals have long sought to understand the dynamics of tobacco consumption, particularly
Tramadol Without A Prescription Trusted site to Buy Ambien how dosage and frequency influence health outcomes. The rise in
Soma For Sale Online prescriptions for these medications has often paralleled the increasing rates of anxiety disorders. For instance, medications like benzodiazepines, which are often prescribed for quick relief of anxiety symptoms, can lead to increased risks of falls, cognitive impairment, and dependency in older patients. As we move forward, the healthcare landscape may continue to evolve, with more
Clonazepam Legally emphasis placed on addressing the mental health, financial, and social aspects of chronic illness alongside treatment. In the last few years, maintenance therapy has emerged as a crucial strategy for managing chronic respiratory diseases. Understanding
Xanax Legally this phenomenon requires careful examination of the underlying mechanisms and a thoughtful approach to treatment. By integrating medications with spasmolytic effects, physical therapy, lifestyle changes, and ongoing communication, patients can work
Lyrica Buy Online towards a pain management plan that addresses not only their physical symptoms but also their overall quality of life.
IndieBio tells us that this batch is going big on diversity, both in terms of gender and geography. The cohort attracted companies from four countries — Brazil, Israel, Turkey and the U.S. are all represented — and 62% of the CEOs in this batch are women. Perhaps predictably, there’s less diversity in the education levels of the IndieBio founders, with 17 Ph.D.s, and all founders hold advanced academic degrees.
The companies are extraordinarily health-forward, with nine focusing on the health of the planet and four tackling challenges in human health. They’re approaching the problems from a bunch of different angles, including materials, foods, industrial biotech, therapeutics and diagnostics.
In a post-pandemic world, the accelerator has seen some changes to its program, too. Before 2020, all companies were expected to travel to San Francisco for four months, but those days are gone. Today, the 13 cohort companies are part of a hybrid program.
“It’s more than just the money,” managing director Po Bronson said in an email to TechCrunch, highlighting the accelerator’s “smart money” chops, “although the fact that we doubled our investment offering to $525,000 doesn’t hurt.”
Let’s take a look at the five most interesting companies in this IndieBio cohort — and what we love about ’em.
Source @TechCrunch
